Lv1
58 积分 2023-07-25 加入
GW201 mediates neuroprotection via allosteric modulation of NMDA receptor activity in the middle cerebral artery occlusion (MCAO) model
8天前
已完结
Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling
1个月前
已完结
Pathway-selective 5-HT1AR agonist as a rapid antidepressant strategy
4个月前
已完结
Targeting protein disorder: the next hurdle in drug discovery
4个月前
已完结
Pharmacokinetic, pharmacodynamic and subjective and effects of the novel 5-HT2A receptor agonist GM-2505 in healthy volunteers
6个月前
已关闭
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
6个月前
已完结
New epilepsy therapies in development
7个月前
已完结
Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy
7个月前
已完结
22. GM-2505 has Rapid Onset Antidepressant Activity and Causes Dose-Dependent Changes in qEEG With Increasing 5-HT2A Receptor Occupancy
7个月前
已完结
The polypharmacology of psychedelics reveals multiple targets for potential therapeutics
7个月前
已完结
皖公网安备34019202002308
